Opus Genetics, Inc. (FRA:R3X1)
1.666
-0.008 (-0.48%)
At close: Dec 19, 2025
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of €117.71 million as of December 19, 2025. Its market cap has increased by 227.21% in one year.
Market Cap
117.71M
Enterprise Value
92.32M
Revenue
12.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.67
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from 17.89M to 117.71M, an increase of 558.10%. That is a compound annual growth rate of 44.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 117.71M | 224.39% |
| Dec 31, 2024 | 36.29M | -41.14% |
| Dec 29, 2023 | 61.65M | -10.30% |
| Dec 30, 2022 | 68.73M | 21.12% |
| Dec 31, 2021 | 56.74M | -1.36% |
| Dec 31, 2020 | 57.52M | 221.61% |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 129.76B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |